Information Library
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
2009 Career Fairs in The Netherlands
May 19, 2009
Every year Quintiles attends several Career Fairs in the Netherlands. See this years list. -
A Meeting of the Minds
August 1, 2008
A Pharma TV interview with Ben Cons -
A New Gold Standard
May 1, 2008
May 2008 - John Doyle, DrPH, practice leader for market access at Quintiles Consulting, discusses the concept of a health economic balance sheet and the need for evidence-based pricing for biopharmaceutical valuation. -
A New Gold Standard for Pricing
September 26, 2008
Dr. John Doyle, practice leader for market access at Quintiles Consulting, introduces the concept of a health economic balance sheet and evidence-based pricing for biopharmaceutical valuation. -
A Testimonial About Innovex Portugal
March 30, 2009
A testimonial about commercialization through Innovex. -
A total commercializing solution
August 13, 2009
ProStrakan opts for an entirely new outsourcing model that delivers benefits above and beyond the standard fee for service model. -
Accelerating a Trial Delayed by Slow Approvals
March 27, 2009
Intense remote monitoring by project coordination center quickly speeds up recruitment -
Accessing the Business Impact of Comparative Effectiveness
November 9, 2009
The increasing use of Health Technology Assessments (HTA) is emerging as a policy issue that could have significant effects on every link in the product development chain. -
Adrian McKemey, Ph.D.
March 25, 2009
Adrian leads the Product Development and Commercialization consulting practice at Quintiles Global Consulting. -
Advanced Gastric Cancer
May 12, 2009
To meet the challenges in patient recruitment, Quintiles relied on its therapeutic experience and extensive global site network to select the study sites most likely to treat patients meeting study entry criteria. In order to assist oncologists in working with the primary-tumor-related inclusion criteria, CRAs provided training to all sites based on a radiological briefing document.